AU5438573A - Dopamine derivatives - Google Patents

Dopamine derivatives

Info

Publication number
AU5438573A
AU5438573A AU54385/73A AU5438573A AU5438573A AU 5438573 A AU5438573 A AU 5438573A AU 54385/73 A AU54385/73 A AU 54385/73A AU 5438573 A AU5438573 A AU 5438573A AU 5438573 A AU5438573 A AU 5438573A
Authority
AU
Australia
Prior art keywords
dopamine derivatives
dopamine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU54385/73A
Other versions
AU472734B2 (en
Inventor
RALPH TUTTLE and JACK MILLS RONALD
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22918877&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU5438573(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of AU5438573A publication Critical patent/AU5438573A/en
Application granted granted Critical
Publication of AU472734B2 publication Critical patent/AU472734B2/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46—Friedel-Crafts reactions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU54385/73A 1972-04-12 1973-04-11 Dopamine derivatives Expired AU472734B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24346672A 1972-04-12 1972-04-12
USUS243,466 1972-04-12

Publications (2)

Publication Number Publication Date
AU5438573A true AU5438573A (en) 1974-10-17
AU472734B2 AU472734B2 (en) 1976-06-03

Family

ID=22918877

Family Applications (1)

Application Number Title Priority Date Filing Date
AU54385/73A Expired AU472734B2 (en) 1972-04-12 1973-04-11 Dopamine derivatives

Country Status (31)

Country Link
JP (2) JPS5825656B2 (en)
KR (1) KR790000113B1 (en)
AR (1) AR203822A1 (en)
AT (1) AT323719B (en)
AU (1) AU472734B2 (en)
BE (1) BE798051A (en)
BG (1) BG23001A3 (en)
CA (1) CA1018188A (en)
CH (2) CH569691A5 (en)
CS (2) CS190448B2 (en)
CY (1) CY963A (en)
DD (1) DD107670B3 (en)
DE (1) DE2317710C2 (en)
DK (1) DK142750C (en)
ES (1) ES413639A1 (en)
FR (1) FR2182947B1 (en)
GB (1) GB1392674A (en)
HK (1) HK50178A (en)
HU (2) HU167597B (en)
IE (1) IE37511B1 (en)
IL (1) IL42016A (en)
KE (1) KE2870A (en)
MY (1) MY7800381A (en)
NL (1) NL174459C (en)
PH (1) PH11041A (en)
PL (2) PL94207B1 (en)
RO (2) RO65105A (en)
SE (1) SE399064B (en)
SU (1) SU496719A3 (en)
YU (2) YU36483B (en)
ZA (1) ZA732136B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH585693A5 (en) * 1974-02-08 1977-03-15 Ciba Geigy Ag
US4342692A (en) * 1980-10-20 1982-08-03 Usv Pharmaceutical Corporation Pyrrolidines
ES8702355A1 (en) * 1981-07-22 1985-07-01 Syntex Inc Substituted pyrrolidine cardiovascular system regulators and antihypertensives, their preparation and use.
JPS6061523A (en) * 1983-09-16 1985-04-09 Shionogi & Co Ltd Oral dobutamine pharmaceutical
ZA881076B (en) * 1987-02-24 1989-10-25 Lilly Co Eli Dobutamine salts
JPH0383364U (en) * 1989-12-18 1991-08-23
AU658188B2 (en) * 1991-05-20 1995-04-06 Tsumura & Co. Phellodendrine analogs and allergy type IV suppressor containing the same as active ingredient
ATE155125T1 (en) * 1993-04-13 1997-07-15 Duphar Int Res PRODUCTION OF DOBUTAMIN COMPOUNDS
EP0620208B1 (en) * 1993-04-13 1997-07-09 Duphar International Research B.V Production of dobutamine compounds
WO2004031129A2 (en) 2002-10-03 2004-04-15 New Era Biotech, Ltd. Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection
CA2560922C (en) 2004-03-26 2014-01-07 New Era Biotech, Ltd. Improvements in or relating to compounds for use in the treatment of aids and other viral diseases and hiv-related infections and compositions containing such compounds, methods of treating such diseases and infections and methods of making such compounds and compositions
GB0804213D0 (en) 2008-03-06 2008-04-16 New Era Biotech Ltd A method of printing or preventing pain
RU2012107457A (en) 2009-07-31 2013-09-10 Когнишн Терапьютикс, Инк. COGNITIVE IMPAIRMENT INHIBITORS
US8802734B2 (en) 2009-09-09 2014-08-12 Novaremed Limited Method of treating or preventing pain
BR112014004414A2 (en) * 2011-08-25 2017-03-28 Cognition Therapeutics Inc compositions and methods for treating neurodegenerative disease
DK3498692T3 (en) 2014-01-31 2022-05-16 Cognition Therapeutics Inc Isoindoline compositions and methods for treating neurodegenerative disease and macular degeneration
JP7218306B2 (en) 2017-05-15 2023-02-06 コグニション セラピューティクス インク． Compositions for treating neurodegenerative diseases
CN114524734B (en) * 2021-12-27 2024-04-26 嘉实（湖南）医药科技有限公司 Preparation method of dobutamine hydrochloride

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2276619A (en) * 1942-03-17 N-phentlaliphatic-dihtoroxyphentnl

Also Published As

Publication number Publication date
JPS58131945A (en) 1983-08-06
CS190448B2 (en) 1979-05-31
DD107670A5 (en) 1974-08-12
HU166213B (en) 1975-02-28
AT323719B (en) 1975-07-25
YU36483B (en) 1984-02-29
YU97673A (en) 1982-02-25
IL42016A0 (en) 1973-06-29
YU37113B (en) 1984-08-31
JPS497237A (en) 1974-01-22
AU472734B2 (en) 1976-06-03
KE2870A (en) 1978-09-01
SE399064B (en) 1978-01-30
DE2317710A1 (en) 1973-10-18
PL90695B1 (en) 1977-01-31
RO70892A (en) 1982-02-26
MY7800381A (en) 1978-12-31
AR203822A1 (en) 1975-10-31
ZA732136B (en) 1974-03-27
HK50178A (en) 1978-09-15
DK142750C (en) 1981-08-17
KR790000113B1 (en) 1979-03-20
DD107670B3 (en) 1988-04-06
GB1392674A (en) 1975-04-30
ES413639A1 (en) 1976-01-16
NL174459C (en) 1984-06-18
BE798051A (en) 1973-10-11
RO65105A (en) 1980-01-15
CH580563A5 (en) 1976-10-15
NL174459B (en) 1984-01-16
SU496719A3 (en) 1975-12-25
PL94207B1 (en) 1977-07-30
PH11041A (en) 1977-10-25
IE37511B1 (en) 1977-08-03
JPS6221343B2 (en) 1987-05-12
CS190406B2 (en) 1979-05-31
IL42016A (en) 1976-05-31
BG23001A3 (en) 1977-05-20
DE2317710C2 (en) 1983-08-04
DK142750B (en) 1981-01-12
NL7305097A (en) 1973-10-16
HU167597B (en) 1975-11-28
FR2182947A1 (en) 1973-12-14
FR2182947B1 (en) 1976-07-02
CH569691A5 (en) 1975-11-28
YU321279A (en) 1983-04-27
CY963A (en) 1978-12-22
CA1018188A (en) 1977-09-27
JPS5825656B2 (en) 1983-05-28

Similar Documents

Publication Publication Date Title
AU472734B2 (en) Dopamine derivatives
AU467361B2 (en) Q-aryl-4-substituted piperidinoalkanol derivatives
AU496759B2 (en) New pregnan-21-oic derivatives
CA1019738A (en) Isothiocyanopyridine derivatives
AU470719B2 (en) Oxazinoindole-and thiazinoinindole derivatives
CA976967A (en) Diphenylalkyllactamimide derivatives
CA1020946A (en) 1-phenoxy-3-phenoxyethylamino-2-propanol derivatives
CA1006514A (en) Beta-aminoketone derivatives
AU470763B2 (en) Pyrano-and thiopyranoindole derivatives
CA1018161A (en) Indan-1-carboxamide derivatives
CA978526A (en) Pyrano- and thiopyranoindole derivatives
CA981684A (en) Cyclopenteno-quinolone derivatives
CA892056A (en) Sulphonamidopyrazolinone derivatives
CA912581A (en) Zearalane derivatives
CA896560A (en) 6-phenyl-dihydropyridazine-3-one derivatives
CA898253A (en) Styryl-naphthalene derivatives
CA899353A (en) 1-hydroxyproline derivatives
CA899886A (en) Oxotremarine derivatives
CA901015A (en) Benzophenonimine derivatives
CA891502A (en) Benhydrylquinuclidinol derivatives
AU477427B2 (en) 2-fluoro-substituted thiazanthene derivatives
CA910910A (en) Pyrimidinylpyrazole derivatives
AU482792B2 (en) Indan-1-carboxamide derivatives
CA904852A (en) Tetrahydrocyclopropadibenzazepine derivatives
CA916153A (en) Dihydropyrimidopyridazine derivatives